teplizumab
Showing 1 - 4 of 4
Type 1 Diabetes Trial in Atlanta (Teplizumab)
Terminated
- Type 1 Diabetes Mellitus
- Teplizumab
-
Atlanta, GeorgiaAtlanta Diabetes Associates
Feb 4, 2022
Diabetes, Type 1 Trial in Belgium, United States (AG019 - Low Dose, Teplizumab, Placebo-AG019)
Completed
- Diabetes Mellitus, Type 1
- AG019 - Low Dose
- +5 more
-
Birmingham, Alabama
- +17 more
Nov 9, 2021
Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk Trial in Canada, Germany, United States
Completed
- Autoantibody Positive
- +3 more
- Teplizumab
- Placebo infusion
-
San Francisco, California
- +18 more
Jul 21, 2020
Type 1 Diabetes Trial in Worldwide (Teplizumab, Placebo)
Completed
- Type 1 Diabetes Mellitus
- Teplizumab
- Placebo
-
Birmingham, Alabama
- +114 more
Feb 4, 2022